Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.71B | 57.65B | 54.83B | 51.05B | 48.65B | 45.48B |
Gross Profit | 8.34B | 8.54B | 8.01B | 7.06B | 6.58B | 5.88B |
EBITDA | 3.79B | 2.97B | 3.20B | 3.42B | 3.08B | 2.66B |
Net Income | 1.15B | 997.00M | 1.17B | 103.00M | 1.08B | 791.00M |
Balance Sheet | ||||||
Total Assets | 30.63B | 29.68B | 30.43B | 30.38B | 30.94B | 30.35B |
Cash, Cash Equivalents and Short-Term Investments | 6.38B | 6.28B | 6.98B | 6.63B | 5.48B | 4.68B |
Total Debt | 6.46B | 5.82B | 7.26B | 8.54B | 9.15B | 9.63B |
Total Liabilities | 14.83B | 14.54B | 15.48B | 16.35B | 16.75B | 16.93B |
Stockholders Equity | 15.79B | 15.13B | 14.95B | 14.03B | 14.18B | 13.42B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.60B | 1.96B | 1.96B | 1.66B | 1.88B |
Operating Cash Flow | 0.00 | 3.21B | 3.67B | 2.97B | 2.59B | 3.17B |
Investing Cash Flow | 0.00 | -1.67B | -1.70B | -940.00M | -998.00M | -1.20B |
Financing Cash Flow | 0.00 | -2.25B | -1.62B | -879.00M | -792.00M | -320.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥25.02B | 13.27 | ― | 16.73% | 80.15% | ||
75 Outperform | ¥16.41B | 17.52 | 1.74% | 5.15% | -15.30% | ||
75 Outperform | ¥16.87B | 11.05 | 3.21% | -5.97% | -37.27% | ||
65 Neutral | $27.25B | 15.35 | -4.01% | 3.14% | 1.00% | 1.98% | |
60 Neutral | ¥13.79B | 16.49 | 1.87% | 0.59% | -15.61% | ||
58 Neutral | ¥12.08B | 207.44 | 1.38% | 10.29% | -52.86% | ||
57 Neutral | ¥13.30B | 24.49 | 0.32% | -2.04% | ― |